VEGFC and breast cancer: These results suggest an important function of VEGF-C in protecting mammary carcinoma cells from oxidative stress or chemotherapy-induced cell death, implying that inhibition of VEGF-C may be a potential adjuvant therapy in combination with ROS-generating chemotherapeutic drugs in the treatment of breast cancers.